SUBSCRIBE
SUBSCRIBE

Northstar Medical Radiosotopes

IN THE PRESS
Business
NorthStar Medical Radioisotopes Executes Supply Agreement with Bayer for Therapeutic Radioisotope Actinium-225 (Ac-225)
July 18, 2023
 · 
3 min read
BioMidwest
NorthStar Medical Radioisotopes Announces Supply Agreement with Nucleus RadioPharma for Alpha-emitting Therapeutic Radioisotope Actinium-225 (Ac-225)
June 27, 2023
 · 
5 min read
BioMidwest
NorthStar Medical Radioisotopes Now Routinely Manufacturing High Activity Copper-67 on its Electron Accelerators for Clarity Pharmaceuticals’ Therapy Clinical Programs
June 26, 2023
 · 
8 min read
BioMidwest
NorthStar Medical Radioisotopes Announces Participation in Upcoming 2023 Guggenheim Radiopharmaceuticals Day
May 9, 2023
 · 
2 min read
Business
NorthStar Medical Radioisotopes Announces Promotion of Jason Vinyard, MBA, MHA, to Vice President, Business Development, Therapeutic Technologies
April 12, 2023
 · 
4 min read
BioMidwest
NorthStar Medical Radioisotopes Announces Presentations at Upcoming Jefferies Radiopharma Innovation Summit
March 30, 2023
 · 
2 min read
BioMidwest
NorthStar Medical Radioisotopes Receives Electron Beam Accelerator for First-of-its-Kind, Commercial-scale U.S. Production of Important Therapeutic Radioisotope Actinium-225 (Ac-225)
March 1, 2023
 · 
6 min read
BioMidwest
NorthStar Medical Radioisotopes Sets New Industry Precedent in Advancing Non-uranium based Commercial Production of Molybdenum-99 (Mo-99)
January 11, 2023
 · 
5 min read
BioMidwest
NorthStar Medical Radioisotopes and Inhibrx Enter into Collaboration Agreement for the Development and Production of Radiopharmaceutical Candidates
January 4, 2023
 · 
7 min read
BioMidwest
NorthStar Medical Radioisotopes Expands Business Platform with New, Patient-focused, Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) Services Unit
November 15, 2022
 · 
6 min read
Load More
JOBS